commercialization agreement
Mainz Biomed Inks Commercialization Deals for Colorectal Cancer Test in UK, Spain
The test combines analysis of DNA, mRNA, and fecal immunohistochemistry to identify cancer in asymptomatic individuals from a stool sample.
Beckman Coulter Partners with MeMed to Develop, Commercialize Host Immune Response Test
MeMed's BV test distinguishes between bacterial and viral infections by measuring three host-immune proteins.
Unilabs, Ambry Genetics Partner to Market Research-Use Genomic Testing Services Internationally
The companies aim to offer genetic testing for biopharma and government-sponsored research in Europe, Latin America, and the Middle East.
Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment
Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network.
Prostatype Genomics, Life Genomics Ink Commercialization Deal for Prostate Cancer Test
Prostatype's test is designed to use gene expression and certain clinical measures to determine a prostate tumor's aggressiveness and guide treatment.